Skip to main content

Published locations for TNF level–based dosing of infliximab does not increase RA remission rate

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. TNF level–based dosing of infliximab does not increase RA remission rate

User login

  • Reset your password
  • /content/tnf-level-based-dosing-infliximab-does-not-increase-ra-remission-rate
  • /internalmedicinenews/article/211035/rheumatoid-arthritis/tnf-level-based-dosing-infliximab-does-not
  • /rheumatologynews/article/211035/rheumatoid-arthritis/tnf-level-based-dosing-infliximab-does-not
  • /rheumatology/article/211035/rheumatoid-arthritis/tnf-level-based-dosing-infliximab-does-not-increase
  • /internalmedicine/article/211035/rheumatoid-arthritis/tnf-level-based-dosing-infliximab-does-not